These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 1729421)

  • 1. Irreversible inhibition of mitochondrial complex I by 1-methyl-4-phenylpyridinium: evidence for free radical involvement.
    Cleeter MW; Cooper JM; Schapira AH
    J Neurochem; 1992 Feb; 58(2):786-9. PubMed ID: 1729421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain mitochondria catalyze the oxidation of 7-(2-aminoethyl)-3,4-dihydro-5-hydroxy-2H-1,4-benzothiazine-3-carboxyli c acid (DHBT-1) to intermediates that irreversibly inhibit complex I and scavenge glutathione: potential relevance to the pathogenesis of Parkinson's disease.
    Li H; Shen XM; Dryhurst G
    J Neurochem; 1998 Nov; 71(5):2049-62. PubMed ID: 9798930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The parkinsonian neurotoxin MPP+ opens the mitochondrial permeability transition pore and releases cytochrome c in isolated mitochondria via an oxidative mechanism.
    Cassarino DS; Parks JK; Parker WD; Bennett JP
    Biochim Biophys Acta; 1999 Jan; 1453(1):49-62. PubMed ID: 9989245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of 1-methyl-4-phenylpyridinium on isolated rat brain mitochondria: evidence for a primary involvement of energy depletion.
    Bates TE; Heales SJ; Davies SE; Boakye P; Clark JB
    J Neurochem; 1994 Aug; 63(2):640-8. PubMed ID: 8035188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irreversible inhibition of mitochondrial complex I by 7-(2-aminoethyl)-3,4-dihydro-5-hydroxy-2H-1,4-benzothiazine-3-carboxyli c acid (DHBT-1): a putative nigral endotoxin of relevance to Parkinson's disease.
    Li H; Dryhurst G
    J Neurochem; 1997 Oct; 69(4):1530-41. PubMed ID: 9326282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of complex I by hydrophobic analogues of N-methyl-4-phenylpyridinium (MPP+) and the use of an ion-selective electrode to measure their accumulation by mitochondria and electron-transport particles.
    Murphy MP; Krueger MJ; Sablin SO; Ramsay RR; Singer TP
    Biochem J; 1995 Mar; 306 ( Pt 2)(Pt 2):359-65. PubMed ID: 7887889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1-Methyl-4-phenylpyridinium (MPP+) induces NADH-dependent superoxide formation and enhances NADH-dependent lipid peroxidation in bovine heart submitochondrial particles.
    Hasegawa E; Takeshige K; Oishi T; Murai Y; Minakami S
    Biochem Biophys Res Commun; 1990 Aug; 170(3):1049-55. PubMed ID: 2167668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is complex II involved in the inhibition of mitochondrial respiration by N-methyl-4-phenylpyridinium cation (MMP+) and N-methyl-beta-carbolines?
    Krueger MJ; Tan AK; Ackrell BA; Singer TP
    Biochem J; 1993 May; 291 ( Pt 3)(Pt 3):673-6. PubMed ID: 8489493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Free radical scavengers protect dopaminergic cell lines from apoptosis induced by complex I inhibitors.
    Seaton TA; Cooper JM; Schapira AH
    Brain Res; 1997 Nov; 777(1-2):110-8. PubMed ID: 9449419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitors of mitochondrial respiration, iron (II), and hydroxyl radical evoke release and extracellular hydrolysis of glutathione in rat striatum and substantia nigra: potential implications to Parkinson's disease.
    Han J; Cheng FC; Yang Z; Dryhurst G
    J Neurochem; 1999 Oct; 73(4):1683-95. PubMed ID: 10501216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of mitochondrial NADH-ubiquinone oxidoreductase activity by 1-methyl-4-phenylpyridinium ion.
    Mizuno Y; Saitoh T; Sone N
    Biochem Biophys Res Commun; 1987 Feb; 143(1):294-9. PubMed ID: 3103619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the characterization of the inhibitory mechanism of 4'-alkylated 1-methyl-4-phenylpyridinium and phenylpyridine analogues in mitochondria and electron transport particles.
    Gluck MR; Youngster SK; Ramsay RR; Singer TP; Nicklas WJ
    J Neurochem; 1994 Aug; 63(2):655-61. PubMed ID: 8035189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylphenylpyridium ion (MPP+) enhances glutamate-induced cytotoxicity against dopaminergic neurons in cultured rat mesencephalon.
    Sawada H; Shimohama S; Tamura Y; Kawamura T; Akaike A; Kimura J
    J Neurosci Res; 1996 Jan; 43(1):55-62. PubMed ID: 8838574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The selective toxicity of 1-methyl-4-phenylpyridinium to dopaminergic neurons: the role of mitochondrial complex I and reactive oxygen species revisited.
    Nakamura K; Bindokas VP; Marks JD; Wright DA; Frim DM; Miller RJ; Kang UJ
    Mol Pharmacol; 2000 Aug; 58(2):271-8. PubMed ID: 10908294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of alpha-ketoglutarate dehydrogenase by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    McNaught KS; Altomare C; Cellamare S; Carotti A; Thull U; Carrupt PA; Testa B; Jenner P; Marsden CD
    Neuroreport; 1995 May; 6(8):1105-8. PubMed ID: 7662887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitric oxide enhances MPP(+) inhibition of complex I.
    Cleeter MW; Cooper JM; Schapira AH
    FEBS Lett; 2001 Aug; 504(1-2):50-2. PubMed ID: 11522295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uptake of the neurotoxin 1-methyl-4-phenylpyridine (MPP+) by mitochondria and its relation to the inhibition of the mitochondrial oxidation of NAD+-linked substrates by MPP+.
    Ramsay RR; Salach JI; Singer TP
    Biochem Biophys Res Commun; 1986 Jan; 134(2):743-8. PubMed ID: 2868716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of mitochondrial succinate oxidation--similarities and differences between N-methylated beta-carbolines and MPP+.
    Fields JZ; Albores RR; Neafsey EJ; Collins MA
    Arch Biochem Biophys; 1992 May; 294(2):539-43. PubMed ID: 1314543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ubiquinone (coenzyme q10) and mitochondria in oxidative stress of parkinson's disease.
    Ebadi M; Govitrapong P; Sharma S; Muralikrishnan D; Shavali S; Pellett L; Schafer R; Albano C; Eken J
    Biol Signals Recept; 2001; 10(3-4):224-53. PubMed ID: 11351130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease.
    Schapira AH; Mann VM; Cooper JM; Dexter D; Daniel SE; Jenner P; Clark JB; Marsden CD
    J Neurochem; 1990 Dec; 55(6):2142-5. PubMed ID: 2121905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.